Cargando…

Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women’s Cancers

We introduce a novel per-gene measure of intra-gene DNA methylation variability (IGV) based on the Illumina Infinium HumanMethylation450 platform, which is prognostic independently of well-known predictors of clinical outcome. Using IGV, we derive a robust gene-panel prognostic signature for ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartlett, Thomas E., Jones, Allison, Goode, Ellen L., Fridley, Brooke L., Cunningham, Julie M., Berns, Els M. J. J., Wik, Elisabeth, Salvesen, Helga B., Davidson, Ben, Trope, Claes G., Lambrechts, Sandrina, Vergote, Ignace, Widschwendter, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667934/ https://www.ncbi.nlm.nih.gov/pubmed/26629914 http://dx.doi.org/10.1371/journal.pone.0143178

Ejemplares similares

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
por: Teschendorff, Andrew E., et al.
Publicado: (2015)

Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer
por: Lambrechts, Sandrina, et al.
Publicado: (2015)

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

Assessment of data transformations for model-based clustering of RNA-Seq data
por: Noel-MacDonnell, Janelle R., et al.
Publicado: (2018)

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
por: Van Nieuwenhuysen, Els, et al.
Publicado: (2019)

Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium
por: Trillsch, Fabian, et al.
Publicado: (2013)

Subject level clustering using a negative binomial model for small transcriptomic studies
por: Li, Qian, et al.
Publicado: (2018)

A Latent Model for Prioritization of SNPs for Functional Studies
por: Fridley, Brooke L., et al.
Publicado: (2011)

Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene
por: Hoivik, Erling A., et al.
Publicado: (2014)

Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence
por: Fridley, Brooke L., et al.
Publicado: (2016)

Corruption of the Intra-Gene DNA Methylation Architecture Is a Hallmark of Cancer
por: Bartlett, Thomas E., et al.
Publicado: (2013)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

The Role of the Tumor Stroma in Ovarian Cancer
por: Davidson, Ben, et al.
Publicado: (2014)

Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2014)

Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer
por: Raghavan, Rama, et al.
Publicado: (2016)

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)

Hyaluronan Synthase and Hyaluronidase Expression in Serous Ovarian Carcinoma is Related to Anatomic Site and Chemotherapy Exposure
por: Weiss, Ilana, et al.
Publicado: (2012)

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
por: Jatoi, Aminah, et al.
Publicado: (2015)

Analysis of variation in NF-κB genes and expression levels of NF-κB-regulated molecules
por: Liu-Mares, Wen, et al.
Publicado: (2007)

Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer
por: Koestler, Devin C, et al.
Publicado: (2014)

Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes
por: Way, Gregory P., et al.
Publicado: (2016)

Ovarian cancer and the immune system
por: Baert, Thaïs, et al.
Publicado: (2017)

Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
por: Werner, Henrica M. J., et al.
Publicado: (2014)

Single versus multiple imputation for genotypic data
por: Fridley, Brooke L, et al.
Publicado: (2009)

Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer
por: Natanzon, Yanina, et al.
Publicado: (2018)

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients - a study of the OVCAD consortium
por: Bachmayr-Heyda, Anna, et al.
Publicado: (2013)

Comparison of tagging single-nucleotide polymorphism methods in association analyses
por: Goode, Ellen L, et al.
Publicado: (2007)

The genetics of gene expression: comparison of linkage scans using two phenotype normalization methods
por: de Andrade, Mariza, et al.
Publicado: (2007)

No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer
por: Goode, Ellen L, et al.
Publicado: (2009)

Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development
por: Jones, Allison, et al.
Publicado: (2013)

C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease
por: Landskron, Johannes, et al.
Publicado: (2017)

AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer
por: Svoboda, Martin, et al.
Publicado: (2016)

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification
por: Olbrecht, Siel, et al.
Publicado: (2021)

Linkage analysis using principal components of gene expression data
por: Atkinson, Elizabeth J, et al.
Publicado: (2007)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome
por: Fridley, Brooke L, et al.
Publicado: (2014)

Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study
por: Jansen, Jolien, et al.
Publicado: (2023)

Low Frequency of ESRRA–C11orf20 Fusion Gene in Ovarian Carcinomas
por: Micci, Francesca, et al.
Publicado: (2014)

Lipocalin 2 expression is associated with aggressive features of endometrial cancer
por: Mannelqvist, Monica, et al.
Publicado: (2012)

HMGA2 expression pattern and TERT mutations in tumors of the vulva
por: AGOSTINI, ANTONIO, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l97cb3ivbe1s97t7vdro0kislp